Diagnosis of Alzheimer's disease patients with rapid cognitive decline in clinical practice: Interest of the Deco questionnaire

Journal of Nutrition, Health and Aging

Volumn 15, Issue 5, 2011, Pages 361-366

  Carcaillon, Laure ^a   Berrutp, G ^b   Sellalm, F ^c,d   Dartigues, J F ^a,e   Gillette, S ^f,g   Pere, J J ^h   Bourdeix, I ^h  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d Hôpitaux Civils de Colmar   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f CHU PURPAN   (France)

^g UNIVERSITÉ PAUL SABATIER   (France)

^h NOVARTIS PHARMA K K   (Japan)

Author keywords

Alzheimer's disease; diagnostic tool; rapid cognitive decline

Indexed keywords

CHOLINESTERASE INHIBITOR; MEMANTINE; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CLINICAL PRACTICE; COGNITIVE DEFECT; DISEASE SEVERITY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; RAPID COGNITIVE DECLINE; RISK FACTOR;

EID: 79960050783     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-011-0047-z     Document Type: Article

References (18)

1. R. S. Doody P. Massman J. K. Dunn 2001 A method for estimating progression rates in Alzheimer disease Arch Neurol 58 3 449 454 11255449 10.1001/archneur.58.3.449 1:STN:280:DC%2BD3M7pvVCiug%3D%3D (Pubitemid 32217462)
2. L. Carcaillon K. Peres J. J. Pere C. Helmer J. M. Orgogozo J. F. Dartigues 2007 Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community Dement Geriatr Cogn Disord 23 6 439 445 17476100 10.1159/000102017 (Pubitemid 46897182)
3. C. Helmer S. Andrieu K. Peres J. M. Orgogozo B. Vellas J. F. Dartigues 2007 Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease Dement Gerialr Cogn Disord 23 3 168 174 10.1159/000098516 (Pubitemid 46333784)
4. S. Gillette-Guyonnet S. Andrieu F. Cortes F. Nourhashemi C. Cantet P. J. Ousset, et al. 2006 Outcome of Alzheimer's disease: potential impact of Cholinesterase inhibitors J Gerontol A Biol Sci Med Sci 61 5 516 520 16720751 (Pubitemid 43794713)
5. M. R. Farlow G. W. Small P. Quarg A. Krause 2005 Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis Dement Geriatr Cogn Disord 20 2-3 192 197 16088144 10.1159/000087301 1:CAS:528:DC%2BD2MXoslKgsrg%3D (Pubitemid 41191637)
6. C. Dumont T. Voisin F. Nourhashemi S. Andrieu M. Koning B. Vellas 2005 Predictive factors for rapid loss on the mini-mental state examination in Alzheimer's disease J Nutr Health Aging 9 3 163 167 15864396 1:STN:280:DC%2BD2M3ivFWjsA%3D%3D (Pubitemid 40592328)
7. S. Gauthier B. Vellas M. Farlow D. Burn 2006 Aggressive course of disease in dementia Alzheimers Dement 2 3 210 217 19595889 10.1016/j.jalz.2006.03.002 (Pubitemid 43843086)
8. K. Ritchie S. Artero J. Touchon 2001 Classification criteria for mild cognitive impairment: a population-based validation study Neurology 56 1 37 42 11148233 1:STN:280:DC%2BD3MzmvFWmtg%3D%3D (Pubitemid 32059649)
9. M. F. Folstein S. F. Folstein P. R. McHugh 1975 "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 3 189 198 1202204 10.1016/0022-3956(75)90026-6 1:STN:280:DyaE28%2FntFKjtw%3D%3D
10. M. P. Lawton E. M. Brody 1969 Assessment of older people: s elf-maintaining arid instrumental activities of daily living Gerontologist 9 3 179 186 5349366 1:STN:280:DyaE3c%2FivV2kug%3D%3D
11. S. Galluzzi L. Cimaschi L. Ferrucci G. B. Frisoni 2001 Mild cognitive impairment: clinical features and review of screening instruments Aging (Milano) 13 3 183 202 1:STN:280:DC%2BD38%2FhvVOmuw%3D%3D (Pubitemid 32600085)
12. B. Dubois 2001 L'épreuve des cinq mots Neurol Psychiatrie Gériatr 1 40 42
13. M. E. Soto S. Andrieu C. Arbus M. Ceccaldi P. Couratier T. Dantoine, et al. 2008 Rapid cognitive decline in Alzheimer's disease. Consensus paper J Nutr Health Aging 12 10 703 713 19043645 1:STN:280:DC%2BD1cjnsV2muw%3D%3D
14. R. O'Hara J. M. Thompson H. C. Kraemer C. Fenn J. L. Taylor L. Ross, et al. 2002 Which Alzheimer patients are at risk for rapid cognitive decline? J Geriatr Psychiatry Neurol 15 4 233 238 12489920 (Pubitemid 35416170)
15. O. L. Lopez J. T. Becker S. Wisniewski J. Saxton D. I. Kaufer S. T. DeKosky 2002 Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease J Neurol Neurosurg Psychiatry 72 3 310 314 11861686 10.1136/jnnp.72.3.310 1:STN:280:DC%2BD387is1eksg%3D%3D (Pubitemid 34185197)
16. S. Marquis M. M. Moore D. B. Howieson G. Sexton H. Payami J. A. Kaye, et al. 2002 Independent predictors of cognitive decline In healthy elderly persons Arch Neurol 59 4 601 606 11939895 10.1001/archneur.59.4.601 (Pubitemid 34289964)
17. M. Musicco K. Palmer G. Salamone F. Lupo R. Perri S. Mosti, et al. 2009 Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors J Neurol 256 8 1288 1295 19353221 10.1007/s00415-009-5116-4
18. L. Teri S. M. McCurry S. D. Edland W. A. Kukull E. B. Larson 1995 Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk fad ors for accelerated decline J Gerontol A Biol Sci Med Sci 50A 1 M49 55 7814789 1:STN:280:DyaK2M7hsVaqtg%3D%3D